Stereochemistry and enantiomeric purity of a novel anxiolytic agent, deramciclane fumarate

The synthesis, stereostructure, and enantiomeric separation by chromatography of a new, chiral anxiolytic agent, deramciclane fumarate (2, (−)‐[1R,2S,4R]‐2‐(2‐dimethylaminoethoxy)‐2‐phenyl‐1,7,7‐trimethylbicyclo[2.2.1]heptane fumarate, EGIS‐3886), is described. The optical antipode and the racemate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chirality (New York, N.Y.) N.Y.), 1999, Vol.11 (9), p.689-693
Hauptverfasser: Ladányi, László, Sztruhár, Ilona, Budai, Zoltán, Lukács, Gyula, Mezei, Tibor, Argay, Gyula, Kálmán, Alajos, Simig, Gyula
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 693
container_issue 9
container_start_page 689
container_title Chirality (New York, N.Y.)
container_volume 11
creator Ladányi, László
Sztruhár, Ilona
Budai, Zoltán
Lukács, Gyula
Mezei, Tibor
Argay, Gyula
Kálmán, Alajos
Simig, Gyula
description The synthesis, stereostructure, and enantiomeric separation by chromatography of a new, chiral anxiolytic agent, deramciclane fumarate (2, (−)‐[1R,2S,4R]‐2‐(2‐dimethylaminoethoxy)‐2‐phenyl‐1,7,7‐trimethylbicyclo[2.2.1]heptane fumarate, EGIS‐3886), is described. The optical antipode and the racemate of compound 2 were also prepared. The structure was determined by single crystal X‐ray diffraction analysis. The enantiomeric separation was accomplished by HPLC on Chiralcel OD (250 × 4.6 mm; 10 μm) and hexane‐ethanol (99.5:0.5) as mobile phase at room temperature. The enantiomeric purity of the synthesized drug substance proved to be very high (>99.9%). Some statements published earlier on the stereostructure of deramciclane fumarate are critically discussed. Chirality 11:689–693, 1999. © 1999 Wiley‐Liss, Inc.
doi_str_mv 10.1002/(SICI)1520-636X(1999)11:9<689::AID-CHIR4>3.0.CO;2-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70777131</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70777131</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3984-e1a3d83dc036bdcc9c884037ef55a885b235126a586d54d05c2d1e7a93b78b413</originalsourceid><addsrcrecordid>eNp9kW9r1TAUh4Mo7jr9CtJXsoG9Jk2TJncijKpbYeyKd7KLbw5peq529s81bXX99qZ2DEHxVSB5-P3OeULICaNLRmn06miTpdkxExENJZfbI6a1PmZspV9LpVer0-xtmJ5nH-M3fEmX6fokCrcPyOKef0gWVGkdUhpHB-RJ191QSrXk8WNywKigMo70gnze9OiwtV-xLrvejYFpigAb0_RlW6MrbbAfXNmPQbsLTNC0P7DyyG3ZVmPvH80XbPqXQYHO1La0lWkw2A21cabHp-TRzlQdPrs7D8mn9--u0vPwYn2WpacXoeVaxSEywwvFC0u5zAtrtVUqpjzBnRBGKZFHXLBIGqFkIeKCChsVDBOjeZ6oPGb8kLyYc_eu_T5g14NfxWI1DdMOHSQ0SRLGJ3Azg9a1XedwB3tX-llHYBQm5QCTcpgUwqQQJuXAGGjwygG8cvitHDhQSNcQwdanPr-rH_Iaiz8yZ8ceuJqBn2WF41-d_638V-N84WPDOdb_G97exxr3DWTCEwHXl2eQyg_JtbyUwPgvpMesTg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70777131</pqid></control><display><type>article</type><title>Stereochemistry and enantiomeric purity of a novel anxiolytic agent, deramciclane fumarate</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Ladányi, László ; Sztruhár, Ilona ; Budai, Zoltán ; Lukács, Gyula ; Mezei, Tibor ; Argay, Gyula ; Kálmán, Alajos ; Simig, Gyula</creator><creatorcontrib>Ladányi, László ; Sztruhár, Ilona ; Budai, Zoltán ; Lukács, Gyula ; Mezei, Tibor ; Argay, Gyula ; Kálmán, Alajos ; Simig, Gyula</creatorcontrib><description>The synthesis, stereostructure, and enantiomeric separation by chromatography of a new, chiral anxiolytic agent, deramciclane fumarate (2, (−)‐[1R,2S,4R]‐2‐(2‐dimethylaminoethoxy)‐2‐phenyl‐1,7,7‐trimethylbicyclo[2.2.1]heptane fumarate, EGIS‐3886), is described. The optical antipode and the racemate of compound 2 were also prepared. The structure was determined by single crystal X‐ray diffraction analysis. The enantiomeric separation was accomplished by HPLC on Chiralcel OD (250 × 4.6 mm; 10 μm) and hexane‐ethanol (99.5:0.5) as mobile phase at room temperature. The enantiomeric purity of the synthesized drug substance proved to be very high (&gt;99.9%). Some statements published earlier on the stereostructure of deramciclane fumarate are critically discussed. Chirality 11:689–693, 1999. © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 0899-0042</identifier><identifier>EISSN: 1520-636X</identifier><identifier>DOI: 10.1002/(SICI)1520-636X(1999)11:9&lt;689::AID-CHIR4&gt;3.0.CO;2-X</identifier><identifier>PMID: 10506429</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Anti-Anxiety Agents - chemistry ; Anti-Anxiety Agents - isolation &amp; purification ; anxiolytic agent ; Bornanes - chemistry ; Bornanes - isolation &amp; purification ; chiral HPLC ; Chromatography, High Pressure Liquid ; deramciclane fumarate ; enantiomeric purity ; stereochemistry ; Stereoisomerism ; X-ray analysis ; X-Ray Diffraction</subject><ispartof>Chirality (New York, N.Y.), 1999, Vol.11 (9), p.689-693</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><rights>Copyright 1999 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3984-e1a3d83dc036bdcc9c884037ef55a885b235126a586d54d05c2d1e7a93b78b413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291520-636X%281999%2911%3A9%3C689%3A%3AAID-CHIR4%3E3.0.CO%3B2-X$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291520-636X%281999%2911%3A9%3C689%3A%3AAID-CHIR4%3E3.0.CO%3B2-X$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,4010,27904,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10506429$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ladányi, László</creatorcontrib><creatorcontrib>Sztruhár, Ilona</creatorcontrib><creatorcontrib>Budai, Zoltán</creatorcontrib><creatorcontrib>Lukács, Gyula</creatorcontrib><creatorcontrib>Mezei, Tibor</creatorcontrib><creatorcontrib>Argay, Gyula</creatorcontrib><creatorcontrib>Kálmán, Alajos</creatorcontrib><creatorcontrib>Simig, Gyula</creatorcontrib><title>Stereochemistry and enantiomeric purity of a novel anxiolytic agent, deramciclane fumarate</title><title>Chirality (New York, N.Y.)</title><addtitle>Chirality</addtitle><description>The synthesis, stereostructure, and enantiomeric separation by chromatography of a new, chiral anxiolytic agent, deramciclane fumarate (2, (−)‐[1R,2S,4R]‐2‐(2‐dimethylaminoethoxy)‐2‐phenyl‐1,7,7‐trimethylbicyclo[2.2.1]heptane fumarate, EGIS‐3886), is described. The optical antipode and the racemate of compound 2 were also prepared. The structure was determined by single crystal X‐ray diffraction analysis. The enantiomeric separation was accomplished by HPLC on Chiralcel OD (250 × 4.6 mm; 10 μm) and hexane‐ethanol (99.5:0.5) as mobile phase at room temperature. The enantiomeric purity of the synthesized drug substance proved to be very high (&gt;99.9%). Some statements published earlier on the stereostructure of deramciclane fumarate are critically discussed. Chirality 11:689–693, 1999. © 1999 Wiley‐Liss, Inc.</description><subject>Anti-Anxiety Agents - chemistry</subject><subject>Anti-Anxiety Agents - isolation &amp; purification</subject><subject>anxiolytic agent</subject><subject>Bornanes - chemistry</subject><subject>Bornanes - isolation &amp; purification</subject><subject>chiral HPLC</subject><subject>Chromatography, High Pressure Liquid</subject><subject>deramciclane fumarate</subject><subject>enantiomeric purity</subject><subject>stereochemistry</subject><subject>Stereoisomerism</subject><subject>X-ray analysis</subject><subject>X-Ray Diffraction</subject><issn>0899-0042</issn><issn>1520-636X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kW9r1TAUh4Mo7jr9CtJXsoG9Jk2TJncijKpbYeyKd7KLbw5peq529s81bXX99qZ2DEHxVSB5-P3OeULICaNLRmn06miTpdkxExENJZfbI6a1PmZspV9LpVer0-xtmJ5nH-M3fEmX6fokCrcPyOKef0gWVGkdUhpHB-RJ191QSrXk8WNywKigMo70gnze9OiwtV-xLrvejYFpigAb0_RlW6MrbbAfXNmPQbsLTNC0P7DyyG3ZVmPvH80XbPqXQYHO1La0lWkw2A21cabHp-TRzlQdPrs7D8mn9--u0vPwYn2WpacXoeVaxSEywwvFC0u5zAtrtVUqpjzBnRBGKZFHXLBIGqFkIeKCChsVDBOjeZ6oPGb8kLyYc_eu_T5g14NfxWI1DdMOHSQ0SRLGJ3Azg9a1XedwB3tX-llHYBQm5QCTcpgUwqQQJuXAGGjwygG8cvitHDhQSNcQwdanPr-rH_Iaiz8yZ8ceuJqBn2WF41-d_638V-N84WPDOdb_G97exxr3DWTCEwHXl2eQyg_JtbyUwPgvpMesTg</recordid><startdate>1999</startdate><enddate>1999</enddate><creator>Ladányi, László</creator><creator>Sztruhár, Ilona</creator><creator>Budai, Zoltán</creator><creator>Lukács, Gyula</creator><creator>Mezei, Tibor</creator><creator>Argay, Gyula</creator><creator>Kálmán, Alajos</creator><creator>Simig, Gyula</creator><general>John Wiley &amp; Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1999</creationdate><title>Stereochemistry and enantiomeric purity of a novel anxiolytic agent, deramciclane fumarate</title><author>Ladányi, László ; Sztruhár, Ilona ; Budai, Zoltán ; Lukács, Gyula ; Mezei, Tibor ; Argay, Gyula ; Kálmán, Alajos ; Simig, Gyula</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3984-e1a3d83dc036bdcc9c884037ef55a885b235126a586d54d05c2d1e7a93b78b413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Anti-Anxiety Agents - chemistry</topic><topic>Anti-Anxiety Agents - isolation &amp; purification</topic><topic>anxiolytic agent</topic><topic>Bornanes - chemistry</topic><topic>Bornanes - isolation &amp; purification</topic><topic>chiral HPLC</topic><topic>Chromatography, High Pressure Liquid</topic><topic>deramciclane fumarate</topic><topic>enantiomeric purity</topic><topic>stereochemistry</topic><topic>Stereoisomerism</topic><topic>X-ray analysis</topic><topic>X-Ray Diffraction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ladányi, László</creatorcontrib><creatorcontrib>Sztruhár, Ilona</creatorcontrib><creatorcontrib>Budai, Zoltán</creatorcontrib><creatorcontrib>Lukács, Gyula</creatorcontrib><creatorcontrib>Mezei, Tibor</creatorcontrib><creatorcontrib>Argay, Gyula</creatorcontrib><creatorcontrib>Kálmán, Alajos</creatorcontrib><creatorcontrib>Simig, Gyula</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Chirality (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ladányi, László</au><au>Sztruhár, Ilona</au><au>Budai, Zoltán</au><au>Lukács, Gyula</au><au>Mezei, Tibor</au><au>Argay, Gyula</au><au>Kálmán, Alajos</au><au>Simig, Gyula</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stereochemistry and enantiomeric purity of a novel anxiolytic agent, deramciclane fumarate</atitle><jtitle>Chirality (New York, N.Y.)</jtitle><addtitle>Chirality</addtitle><date>1999</date><risdate>1999</risdate><volume>11</volume><issue>9</issue><spage>689</spage><epage>693</epage><pages>689-693</pages><issn>0899-0042</issn><eissn>1520-636X</eissn><abstract>The synthesis, stereostructure, and enantiomeric separation by chromatography of a new, chiral anxiolytic agent, deramciclane fumarate (2, (−)‐[1R,2S,4R]‐2‐(2‐dimethylaminoethoxy)‐2‐phenyl‐1,7,7‐trimethylbicyclo[2.2.1]heptane fumarate, EGIS‐3886), is described. The optical antipode and the racemate of compound 2 were also prepared. The structure was determined by single crystal X‐ray diffraction analysis. The enantiomeric separation was accomplished by HPLC on Chiralcel OD (250 × 4.6 mm; 10 μm) and hexane‐ethanol (99.5:0.5) as mobile phase at room temperature. The enantiomeric purity of the synthesized drug substance proved to be very high (&gt;99.9%). Some statements published earlier on the stereostructure of deramciclane fumarate are critically discussed. Chirality 11:689–693, 1999. © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>10506429</pmid><doi>10.1002/(SICI)1520-636X(1999)11:9&lt;689::AID-CHIR4&gt;3.0.CO;2-X</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0899-0042
ispartof Chirality (New York, N.Y.), 1999, Vol.11 (9), p.689-693
issn 0899-0042
1520-636X
language eng
recordid cdi_proquest_miscellaneous_70777131
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Anti-Anxiety Agents - chemistry
Anti-Anxiety Agents - isolation & purification
anxiolytic agent
Bornanes - chemistry
Bornanes - isolation & purification
chiral HPLC
Chromatography, High Pressure Liquid
deramciclane fumarate
enantiomeric purity
stereochemistry
Stereoisomerism
X-ray analysis
X-Ray Diffraction
title Stereochemistry and enantiomeric purity of a novel anxiolytic agent, deramciclane fumarate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T10%3A15%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stereochemistry%20and%20enantiomeric%20purity%20of%20a%20novel%20anxiolytic%20agent,%20deramciclane%20fumarate&rft.jtitle=Chirality%20(New%20York,%20N.Y.)&rft.au=Lad%C3%A1nyi,%20L%C3%A1szl%C3%B3&rft.date=1999&rft.volume=11&rft.issue=9&rft.spage=689&rft.epage=693&rft.pages=689-693&rft.issn=0899-0042&rft.eissn=1520-636X&rft_id=info:doi/10.1002/(SICI)1520-636X(1999)11:9%3C689::AID-CHIR4%3E3.0.CO;2-X&rft_dat=%3Cproquest_cross%3E70777131%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70777131&rft_id=info:pmid/10506429&rfr_iscdi=true